Tolerance to bronchodilation during treatment with long-acting beta-agonists, a randomised controlled trial
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-993X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Tolerance to bronchodilation during treatment with long-acting beta-agonists, a randomised controlled trial ; volume:6 ; number:1 ; day:16 ; month:9 ; year:2005 ; pages:1-7 ; date:12.2005
Respiratory research ; 6, Heft 1 (16.9.2005), 1-7, 12.2005
- Urheber
-
Haney, Sarah
- Beteiligte Personen und Organisationen
-
Hancox, Robert J.
SpringerLink (Online service)
- DOI
-
10.1186/1465-9921-6-107
- URN
-
urn:nbn:de:1111-201606035473
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Haney, Sarah
- Hancox, Robert J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Potential implications of long-acting GLP-1 receptor agonists for critically ill
Add-on Therapy for Symptomatic Asthma despite Long-Acting Beta-Agonists/Inhaled Corticosteroid
Prescribing of long-acting beta-2-agonists/inhaled corticosteroids after the SMART trial
Long-Acting Reversible Contraception
Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
Development of long-acting ARV’s
RETRACTED ARTICLE: Inhaled corticosteroids and long-acting beta-agonists in adult asthma: a winning combination in all?
Creation of a long-acting nanoformulated dolutegravir
Long-acting beta-agonists plus inhaled corticosteroids safety: a systematic review and meta-analysis of non-randomized studies
Risk of active tuberculosis among COPD patients treated with fixed combinations of long-acting beta2 agonists and inhaled corticosteroids
A Network Meta-Analysis of Long-Acting Muscarinic Antagonist (LAMA) and Long-Acting β2-Agonist (LABA) Combinations in COPD
Potential implications of long-acting GLP-1 receptor agonists for critically ill
Add-on Therapy for Symptomatic Asthma despite Long-Acting Beta-Agonists/Inhaled Corticosteroid
Prescribing of long-acting beta-2-agonists/inhaled corticosteroids after the SMART trial
Long-Acting Reversible Contraception
Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
Development of long-acting ARV’s
RETRACTED ARTICLE: Inhaled corticosteroids and long-acting beta-agonists in adult asthma: a winning combination in all?
Creation of a long-acting nanoformulated dolutegravir
Long-acting beta-agonists plus inhaled corticosteroids safety: a systematic review and meta-analysis of non-randomized studies
Risk of active tuberculosis among COPD patients treated with fixed combinations of long-acting beta2 agonists and inhaled corticosteroids
A Network Meta-Analysis of Long-Acting Muscarinic Antagonist (LAMA) and Long-Acting β2-Agonist (LABA) Combinations in COPD
Potential implications of long-acting GLP-1 receptor agonists for critically ill
Add-on Therapy for Symptomatic Asthma despite Long-Acting Beta-Agonists/Inhaled Corticosteroid
Prescribing of long-acting beta-2-agonists/inhaled corticosteroids after the SMART trial
Long-Acting Reversible Contraception
Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
Development of long-acting ARV’s
RETRACTED ARTICLE: Inhaled corticosteroids and long-acting beta-agonists in adult asthma: a winning combination in all?
Creation of a long-acting nanoformulated dolutegravir
Long-acting beta-agonists plus inhaled corticosteroids safety: a systematic review and meta-analysis of non-randomized studies
Risk of active tuberculosis among COPD patients treated with fixed combinations of long-acting beta2 agonists and inhaled corticosteroids